Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting

E. Wardelmann, R. L. Haas, J. V.M.G. Bovée, Ph Terrier, A. Lazar, C. Messiou, C. Lepechoux, W. Hartmann, F. Collin, C. Fisher, G. Mechtersheimer, A. P. Deitos, S. Stacchiotti, R. L. Jones, A. Gronchi, S. Bonvalot

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Abstract

At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This manuscript, produced by a European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) endorsed task force, aims to propose standardization of the pathological examination process and the reporting of STS resection specimens after neoadjuvant radio- and/or chemotherapy.

Original languageEnglish (US)
Pages (from-to)84-95
Number of pages12
JournalEuropean Journal of Cancer
Volume53
DOIs
StatePublished - Jan 2016

Keywords

  • Chemotherapy
  • Guideline
  • Pathology
  • Radiotherapy
  • Response evaluation
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting'. Together they form a unique fingerprint.

Cite this